Replies to post #35033 on OncoSec Medical Inc (ONCSQ)

[trading.jeff]

$25/share, minimum, sounds good to me as a buyout price. ;-)

$ONCS

[Titan V]

Merck may pursue combo for H&N in the near future. The FDA accepted an sBLA from Merck for Keytruda yesterday actually.

http://www.businesswire.com/news/home/20160413005160/en/FDA-Accepts-Supplemental-Biologics-License-Application-sBLA

I really hope ONCS can prove efficacy on Melanoma combo with a bang so that it can bargain a nice premium for other indications, including potential new ones that are hard to reach, for which they have the "go anywhere device" in R&D at the moment.

[dr_lowenstein]

Really?? is that the same Merck that does not even have a partnership agreement with ONCS?